Search

everythinglearnresearchcommunity

for

Search:↓

The study created a new model to better understand human hair growth and health.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

The document concludes that proper diagnosis and treatment of nonscarring alopecias can improve quality of life and hair regrowth is possible as the hair follicle remains intact.

Hair transplantation is highly effective with careful technique and attention to patient needs.

A new hair transplant method combines individual and group follicles for better results and efficiency.

A new eyelid shampoo improved eyelid hygiene and eyelash length in people with Meibomian Gland Dysfunction.

Minoxidil helps stimulate hair growth and enlarge small follicles in common hair loss, but doesn't stop it, and its effects can be boosted when combined with finasteride.

Hair thickness decreases from the upper to lower areas of the back of the head, affecting hair transplant results.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

Ruxolitinib treatment may cause eyelash growth.

Immune cells affect hair growth and could lead to new hair loss treatments.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Latanoprost, a glaucoma medication, caused excessive eyelid hair growth in many patients.

Some vaccines, like the hepatitis B vaccine, might be linked to the hair loss condition Alopecia Areata, but more research is needed.

Eyelash loss can indicate various health issues, and excessive growth may be linked to certain conditions or medications; both require careful examination and tailored treatment.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

A new treatment for hair loss uses tiny lipid carriers to deliver a mix of minoxidil and latanoprost directly to hair follicles, promoting hair growth and being well tolerated by the skin.

A substance called prostaglandin D2 is linked to stopping hair growth in men with common baldness.

The document concludes that understanding hair and feather regeneration can help develop new regenerative medicine strategies.

Mice without certain skin proteins had abnormal skin and hair development.

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

The combination of Arginine Silicate Inositol Complex and a new form of Biotin improved hair and nail growth in rats.

Trichloroacetic acid is a safe and effective treatment for hair loss in alopecia areata patients.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Transverse sections are better for non-scarring hair loss, vertical sections are better for lichen planopilaris, and either method works for other scarring hair loss types.

Targeting the PGD2-DP2 pathway may help treat hair loss.

Bimatoprost can cause excessive eyelash growth.